|
Advanced Medical Solutions Group PLC on Thursday said it is confident of meeting market expectations for 2025 and expects to report increased earnings. The Cheshire, England-based surgical dressings company said it expects to report revenue of around £228.5 million for 2025, up 29% from £177.5 million in 2024. The firm said it expects to report earnings before interest, tax, depreciation and amortisation between £49.5 million and £50.0 million, up between 23% and 24% from £40.2 million. Advanced Medical Solutions said its performance was driven by ‘continued strong growth’ across key surgical product categories and a ‘good recovery’ in its Woundcare business. It added that this offset some elements of destocking in the Peters Surgical business-to-business area. The integration of Peters Surgical and Syntacoll remains on track, Advanced Medical Solutions said. It added that commercial synergies ‘contributed positively’ during the year, while operational synergies are on track to be realised during 2027 onwards. The company completed the acquisition of speciality surgical products firm Peters Surgical in July 2024 for €132.5 million, while Syntacoll was bought in March 2024 for €1 million. ‘Our surgical business has recorded another period of strong performance, and we have also benefited from the restructuring of our woundcare franchise. Our portfolio is now broader and stronger than at any point in the group’s history, and our pipeline includes a number of exciting and significant opportunities for future growth,’ said Chief Executive Officer Chris Meredith. ‘The integration of Peters Surgical has accelerated the expansion of our geographic footprint, and our plans for further penetration into the US market are well advanced. We remain confident in delivering another strong performance in 2026 and over the long-term, supported by the sustained momentum across the business.’ Shares in Advanced Medical Solutions were up 1.2% at 224.62 pence on Thursday morning in London. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
